284 related articles for article (PubMed ID: 29706302)
1. The role of proton beam therapy in central neurocytoma: A single-institution experience.
Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features, Treatment, and Long-term Outcomes of Central Neurocytoma: A 20-Year Experience at a Single Center.
Wang M; Zhou P; Zhang S; Liu X; Lv L; Wang Z; Ye F; Wang X; Jiang S
World Neurosurg; 2018 Jan; 109():e59-e66. PubMed ID: 28958923
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma.
Chen YD; Li WB; Feng J; Qiu XG
Radiat Oncol; 2014 Nov; 9():242. PubMed ID: 25373333
[TBL] [Abstract][Full Text] [Related]
5. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.
Mercado CE; Hartsell WF; Simone CB; Tsai HK; Vargas CE; Zhu HJ; Henderson RH; Zeng J; Larson GL; Hoppe BS
Acta Oncol; 2019 Jul; 58(7):1036-1040. PubMed ID: 30784340
[No Abstract] [Full Text] [Related]
6. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
Imber BS; Braunstein SE; Wu FY; Nabavizadeh N; Boehling N; Weinberg VK; Tihan T; Barnes M; Mueller S; Butowski NA; Clarke JL; Chang SM; McDermott MM; Prados MD; Berger MS; Haas-Kogan DA
J Neurooncol; 2016 Jan; 126(1):193-200. PubMed ID: 26493740
[TBL] [Abstract][Full Text] [Related]
7. Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional audit.
Pawar D; Chatterjee A; Epari S; Sahay A; Janu A; Krishnatry R; Goda JS; Shetty P; Moiyadi A; Gupta T
J Clin Neurosci; 2021 Feb; 84():91-96. PubMed ID: 33358093
[TBL] [Abstract][Full Text] [Related]
8. Central neurocytoma: management recommendations based on a 35-year experience.
Leenstra JL; Rodriguez FJ; Frechette CM; Giannini C; Stafford SL; Pollock BE; Schild SE; Scheithauer BW; Jenkins RB; Buckner JC; Brown PD
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1145-54. PubMed ID: 17187939
[TBL] [Abstract][Full Text] [Related]
9. Central Versus Extraventricular Neurocytoma in Children: A Clinicopathologic Comparison and Review of the Literature.
Zacharoulis S; Morales La Madrid A; Bandopadhayay P; Chi SN; Manley P; Ullrich NN; Marcus K; Goumnerova L; Scott RM; Proctor M; Young-Poussaint T; De Girolami U; Kieran MW
J Pediatr Hematol Oncol; 2016 Aug; 38(6):479-85. PubMed ID: 27438020
[TBL] [Abstract][Full Text] [Related]
10. Treatment Results of Gamma Knife Radiosurgery for Central Neurocytoma: Report of a Japanese Multi-Institutional Cooperative Study.
Yamanaka K; Iwai Y; Shuto T; Kida Y; Sato M; Hayashi M; Kondo T; Hirai H; Hori R; Kubo K; Mori H; Nagano O; Serizawa T
World Neurosurg; 2016 Jun; 90():300-305. PubMed ID: 26987638
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated neurocytoma: what is the best available treatment?
Rades D; Fehlauer F; Lamszus K; Schild SE; Hagel C; Westphal M; Alberti W
Neuro Oncol; 2005 Jan; 7(1):77-83. PubMed ID: 15701284
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Clinical Outcomes of Pencil Beam Scanning Proton Therapy for Benign and Non-benign Intracranial Meningiomas.
Murray FR; Snider JW; Bolsi A; Lomax AJ; Walser M; Kliebsch U; Schneider RA; Weber DC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1190-1198. PubMed ID: 28939227
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
14. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
[TBL] [Abstract][Full Text] [Related]
15. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors.
Gentile MS; Yeap BY; Paganetti H; Goebel CP; Gaudet DE; Gallotto SL; Weyman EA; Morgan ML; MacDonald SM; Giantsoudi D; Adams J; Tarbell NJ; Kooy H; Yock TI
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):719-729. PubMed ID: 29413284
[TBL] [Abstract][Full Text] [Related]
16. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
17. Central neurocytoma: Clinical characteristics, patterns of care, and survival.
Dutta SW; Kaleem TA; Muller DA; Peterson J; Harrell AC; Quinones-Hinojosa A; Trifiletti DM
J Clin Neurosci; 2018 Jul; 53():106-111. PubMed ID: 29685410
[TBL] [Abstract][Full Text] [Related]
18. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
19. Atypia predicting prognosis for intracranial extraventricular neurocytomas.
Kane AJ; Sughrue ME; Rutkowski MJ; Aranda D; Mills SA; Lehil M; Fang S; Parsa AT
J Neurosurg; 2012 Feb; 116(2):349-54. PubMed ID: 22054208
[TBL] [Abstract][Full Text] [Related]
20. Central Neurocytoma Treatment Modalities: A Systematic Review Assessing the Outcomes of Combined Maximal Safe Resection and Radiotherapy with Gross Total Resection.
Mahavadi AK; Patel PM; Kuchakulla M; Shah AH; Eichberg D; Luther EM; Komotar RJ; Ivan ME
World Neurosurg; 2020 May; 137():e176-e182. PubMed ID: 32001392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
